TNFSF10 and colorectal carcinoma: Nevertheless, due to the low expression of death receptors, some CRC cells, such as HT29, showed moderate resistance (IC50s > 50 nM) to TRAIL (Figure 1(C, D)), suggesting the need to improve the cytotoxicity of TRAIL in these cells.